CIK 0001621227 · Non-accelerated filer<br>Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44 1235 430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 10 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-12 | Wood Gavin Chief Financial Officer | Grant or award · Option to purchase Ordinary Shares | +1,407,072 | 1,407,072 | ||
| 2022-01-12 | Wood Gavin Chief Financial Officer | Grant or award · Option to purchase Ordinary Shares | +314,256 | 314,256 | ||
| 2022-01-12 | Bertrand William C JR Chief Operating Officer | Sale | −2,248 | $3.54 | $8K | 3,754 |
| 2022-01-12 | Lunger John Chief Patient Supply Officer | Sale | −1,076 | $3.54 | $4K | 1,749 |
| 2022-01-12 | Norry Elliot Chief Medical Officer | Grant or award · Option to purchase Ordinary Shares | +2,110,608 | 2,110,608 | ||
| 2022-01-12 | Norry Elliot Chief Medical Officer | Grant or award · Option to purchase Ordinary Shares | +471,360 | 471,360 | ||
| 2022-01-12 | Norry Elliot Chief Medical Officer | Sale | −854 | $3.54 | $3K | 1,383 |
| 2022-01-12 | Rawcliffe Adrian Chief Executive Officer | Sale | −3,046 | $3.54 | $11K | 3,356 |
| 2022-01-12 | Bertrand William C JR Chief Operating Officer | Grant or award · Option to purchase Ordinary Shares | +1,407,072 | 1,407,072 | ||
| 2022-01-12 | Bertrand William C JR Chief Operating Officer | Grant or award · Option to purchase Ordinary Shares | +314,256 | 314,256 | ||
| 2022-01-12 | Rawcliffe Adrian Chief Executive Officer | Grant or award · Option to purchase Ordinary Shares | +4,690,224 | 4,690,224 | ||
| 2022-01-12 | Rawcliffe Adrian Chief Executive Officer | Grant or award · Option to purchase Ordinary Shares | +1,047,480 | 1,047,480 | ||
| 2022-01-11 | Bertrand William C JR Chief Operating Officer | Sale | −3,770 | $3.56 | $13K | 6,343 |
| 2022-01-11 | Lunger John Chief Patient Supply Officer | Sale | −3,770 | $3.56 | $13K | 6,343 |
| 2022-01-11 | Norry Elliot Chief Medical Officer | Sale | −3,770 | $3.56 | $13K | 6,343 |
| 2022-01-11 | Rawcliffe Adrian Chief Executive Officer | Sale | −14,362 | $3.56 | $51K | 15,978 |
| 2022-01-04 | Bertrand William C JR Chief Operating Officer | Sale | −3,490 | $4.06 | $14K | 5,873 |
| 2022-01-04 | Lunger John Chief Patient Supply Officer | Sale | −1,070 | $4.06 | $4K | 1,755 |
| 2022-01-04 | Norry Elliot Chief Medical Officer | Sale | −849 | $4.06 | $3K | 1,388 |
| 2022-01-04 | Rawcliffe Adrian Chief Executive Officer | Sale | −5,532 | $4.06 | $22K | 6,172 |
Page 10 of 23 · 454 trades